Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Antonio José Rullán

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Articles (28)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (13)

Timothy Budden

Lecturer

University of Liverpool

UNITED KINGDOM

View details

James Larkin

Professor

UNITED KINGDOM

View details

Maggie Chon U Cheang

Group Leader

Institute of Cancer Research

UNITED KINGDOM

View details

Selvam Thavaraj

University of Malaya

MALAYSIA

View details

Elizabeth Appleton

Speciality Registrar

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Ignacio Melero

SPAIN

View details

Alvaro Teijeira

Centro de Investigación Médica Aplicada, Universidad de Navarra

SPAIN

View details

Shane Foo

Senior Research Fellow

King’s College London

UNITED KINGDOM

View details

David S. Hong

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ana Catalan

Professor

King's College London Institute of Psychiatry Psychology and Neuroscience

UNITED KINGDOM

View details

Fiona Byrne

The Francis Crick Institute

UNITED KINGDOM

View details

Dragomir Krastev

Institute of Cancer Research

UNITED KINGDOM

View details

Beatriz Castelo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio José Rullán

Research Interests

Explore related searches

Articles (28)

71 Integrated spatial multi-omics reveals tumour immune microenvironment programmes underlying durable response and resistance to dual ICI therapy in ccRCC

Addition of chemotherapy to radiotherapy promotes progenitor-exhausted CD8⁺ T-cell clonal dominance in head and neck cancer

Setanaxib Added to Pembrolizumab for Fibroblast-Rich, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: a Phase 2 Randomized Study

“SMAC”-Down for the Apoptosis-Restoring Drug, Xevinapant: What Does Its Story Reveal?

Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

Decision regret and toxicity perception following adjuvant pembrolizumab in renal cell carcinoma.

Tumour biology

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Renal cell carcinoma with cavoatrial ventricular involvement

Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studies.

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion.

Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis

Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer

Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium

What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study

Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity

Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion (vol 16, 4855, 2025)

Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma

A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis

A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies

Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy

Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies

A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer

Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy

A FIJI macro for quantifying pattern in extracellular matrix

Collaborators (13)

Timothy Budden

James Larkin

Maggie Chon U Cheang

Selvam Thavaraj

Elizabeth Appleton

Ignacio Melero

Alvaro Teijeira

Shane Foo

David S. Hong

Ana Catalan

Fiona Byrne

Dragomir Krastev

Beatriz Castelo

Make your next move.